Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.
Search Criteria
Gene/CloneSpeciesStageAnatomy ItemExperimenter
aplnrxenopus   

Too many results?Too few results?

Experiment details for aplnr



ETS family protein ETV2 is required for initiation of the endothelial lineage but not the hematopoietic lineage in the Xenopus embryo.

Gene Clone Species Stages Anatomy
aplnr.L laevis NF stage 33 and 34 branchial arch , tail bud , posterior cardinal vein , ophthalmic artery , duct of Cuvier , [+]

Display additional annotations [+]
  Figure 5. Inhibition of ETV2 function strongly reduces endothelial, but not hematopoietic marker expression. A,B: Antisense etv2 morpholino oligomer 1 (MO1) efficiently inhibits enhanced green fluorescent protein (EGFP) expression from a target transcript in control experiments. A: Brightfield and fluorescent image of embryos injected with etv2-EGFP fusion transcript and etv2 mismatch control MO (CoMO), showing strong EGFP fluorescence. B: Brightfield and fluorescent image of embryos injected with etv2-EGFP fusion transcript and etv2 MO1. EGFP fluorescence is almost eliminated. C-M: Embryos injected with control MO (CoMo) or etv2 MO1 and assayed for marker gene expression (as indicated) by in situ hybridization. All embryos were assayed at approximately stage 32. Inset boxes in panels C-H, show slightly enlarged and/or increased contrast views centered on the intersegmental vessels and posterior cardinal vein. C-H: Treatment with etv2 MO1 effectively eliminated expression of the endothelial marker genes flk1, aplnr, and erg. In H, expression of erg in neural crest cells in the branchial arch region (open arrowhead) is unchanged. I: etv2 MO1 knockdown of endothelial marker expression is efficiently rescued with etv2 mRNA. All embryos were injected with 50 ng of MO1 plus varying amounts of etv2 mRNA as indicated. Marker gene expression was assayed by in situ hybridization and embryos showing mostly normal endothelial pattern were scored as wild-type. The number in each bar indicates the number of embryos scored for each treatment. Asterisks show statistically significant differences relative to value of MO1 alone, analyzed using Chi-squared test. J-O: Treatment with etv2 MO1 had no detectable effect on expression of myeloid (runx1 and spib) or erythroid (tadpole alpha -globin) markers.